QUESTS - QUantum Enhanced Scanning Technology for community healthcare Settings

磁共振成像（MRI）和计算机断层扫描（CT）等医疗扫描仪对现代医疗保健至关重要。尽管它们具有灵活性，但由于其尺寸，资本成本和运行成本，医疗扫描仪的使用受到限制，所有这些都限制了它们在医院的使用。因此，英国每百万人拥有6.1台MRI扫描仪（约500台，提供380万次扫描[1]）。QU ** antum ** E ** enhanced ** S ** canning ** T ** technology for community healthcare ** S ** ettings（** QUESTS **）是一款小型多感官医疗扫描仪，适用于传统MRI和CT设备不太适合的环境。目标环境可以是：全科医生手术室、社区诊所、药剂师、救护车和移动的军事医院。该项目旨在通过分散扫描能力增强社区医疗保健。这为提高诊断的时钟速度和治疗速度提供了机会，从而改善了患者的治疗效果，同时降低了扫描的总体成本。QUESTS计划将通过桌面研究（第1阶段）和原型（第2阶段）解决技术挑战。第1阶段报告将包含：1.临床和NHS需求的定义2.系统概念3.技术可行性研究，包括文献综述4。IP美化和捕获5.监管和测试途径概述6.精益生产研究7.市场路线和商业计划8.包含缓解措施的风险登记册第2阶段将输出：1.小型子系统演示器的详细设计2.制造和测试子系统演示器3.小规模示范结果报告4.修改子系统设计和全系统原型的详细设计5.搭建了全系统样机并进行了演示6.审查和报告结果7.更新了第1阶段的风险、IP、商业和生产计划QUESTS项目由MetLase（Unipart子公司）领导，分包支持来自：苏塞克斯大学、谢菲尔德哈勒姆大学、谢菲尔德儿童医院、Medilink和Unipart物流

Medical scanners such as Magnetic Resonance Imaging (MRI) and Computerised Tomography (CT) are critical to modern healthcare. Despite their flexibility, the use of medical scanners is restricted because of their: size, capital cost, and running costs, all of which limits their use to hospitals. Consequently, the UK has 6.1 MRI scanners per million people (approx 500, delivering 3.8 million scans\[1\]).**QU**antum **E**nhanced **S**canning **T**echnology for community healthcare **S**ettings (**QUESTS**) is a small form-factor multi-sensorial medical scanner, for environments where traditional MRI and CT equipment is poorly suited. Targeted environments could be; GPs surgeries, community clinics, pharmacists , ambulances and mobile military hospitals. The project aims to empower community-based healthcare with decentralising scanning capability. This offers the opportunity to both increase the clock-speed of diagnosis and speed of treatment, leading to improved patient outcomes, while lowering the overall cost of scanning.The QUESTS programme will address the technical challenges with a desktop study (phase1) and prototype (phase2). The phase1 report will contain:1. Definition of clinical and NHS need2. System concept3. Technical feasibility study, including a literature review4. IP landscaping and capture5. Overview of regulatory and testing pathways6. Lean manufacturing study7. Route-to-market and commercial plan8. Risk register with mitigationsPhase2 will output:1. Detailed design of small-scale sub-system demonstrators2. Manufacture and test subsystem demonstrators3. Report of small-scale demonstrator results4. Revised sub-system design and detailed design of full-system prototype5. Built full-system prototype and demonstrate6. Review and report results7. Updated risk, IP, commercial and manufacturing plans from phase1The QUESTS programme is being lead by MetLase (a Unipart subsidiary) with sub-contracted support from: The university of Sussex, Sheffield Hallam University, Sheffield Children's Hospital, Medilink, and Unipart Logistics